BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Indivior Announces Q3 2023 Financial Results

  Indivior PLC announced its financial results for the period ending September 30, 2023.

  November 9, 2023

   · 

  1 min read
• Business

  Former Amryt Pharma Leadership Team join Poolbeg

  Poolbeg Pharma, a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announces the appointment of key former executives of Amryt Pharma plc to its leadership team.

  November 9, 2023

   · 

  6 min read
• Angle PLC Announces Launch of PD-L1 Test to Support Cancer Studies

  ANGLE plc is delighted to announce the launch of its Portrait® PD-L1 test for the evaluation of PD-L1 protein expression on CTCs following extensive development and optimisation.

  November 9, 2023

   · 

  5 min read
• Genetown

  invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma

  invIOs GmbH, a privately held biotechnology company developing novel therapies for cancer, and Dana-Farber Cancer Institute have entered into a preclinical research collaboration to evaluate invIOs’ small molecule INV501 as a potential treatment for glioblastoma.

  November 9, 2023

   · 

  5 min read
• Business

  EDAP Announces Third Quarter 2023 Financial Results

  EDAP TMS SA, the global leader in robotic energy-based therapies, reported unaudited financial results for the third quarter ending September 30, 2023.

  November 9, 2023

   · 

  19 min read
• BioMidwest

  Biodesix to Participate in Two Upcoming Investor Conferences in November 2023

  Biodesix, Inc. announced Scott Hutton, Chief Executive Officer, will participate in two upcoming investor conferences.

  November 9, 2023

   · 

  3 min read
• Affimed Announces Acimtamig as International Nonproprietary Name for AFM13

  Affimed N.V. announced that the International Nonproprietary Names Expert Committee of the World Health Organization has selected “acimtamig” for the nonproprietary name of the Company’s investigational drug for CD30-positive Lymphomas, previously known as AFM13.

  November 9, 2023

   · 

  4 min read
• Business

  3M Announces Leadership Changes

  In conjunction with the planned spin-off of the Health Care Business, we are announcing the departure of Jeff Lavers, group president, Health Care Business Group, effective Dec. 1.

  November 9, 2023

   · 

  5 min read
• Genetown

  Arch Therapeutics Provides Year End Operational Update

  Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical products, provided a year-end operational update, including key performance metrics related to the ongoing commercialization activities for the Company’s first product, AC5® Advanced Wound System.

  November 9, 2023

   · 

  6 min read
• BioMidwest

  Myriad Genetics to Participate in Stephens Annual Investment Conference

  Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced Myriad management will participate in the Stephens Annual Investment Conference in Nashville, TN with a fireside chat on Wednesday, November 15 at 2:00 p.m. ET.

  November 9, 2023

   · 

  1 min read